Literature DB >> 29045340

Cause of renal infarction: a retrospective analysis of 186 consecutive cases.

Anne-Laure Faucon1,2, Guillaume Bobrie1, Anne-Sophie Jannot3,2,4, Arshid Azarine5, Pierre-François Plouin1, Michel Azizi1,2,6, Laurence Amar1,2.   

Abstract

BACKGROUND: Renal infarction can cause abrupt and severe hypertension and less frequently renal failure. Renal infarction results from disruption of renal blood flow in the main ipsilateral renal artery or in a segmental branch. Underlying mechanism is either general, 'embolic' or 'thrombophilic', or local related to primary 'renal artery lesion'. It depends on various causes. In absence of an identified cause, renal infarction is classified as 'idiopathic'. Previous studies report a significant number of 'idiopathic' renal infarction.
OBJECTIVE: The aim of this study was to analyze various renal infarction causes.
METHODS: Between July 2000 and June 2015, 259 consecutive patients with renal infarction were admitted to our hospital center and retrospectively identified from weekly multidisciplinary round. Main clinical and biological characteristics were extracted from clinical data warehouse. Renal imaging was reviewed by two readers unaware of the diagnosis.
RESULTS: Of 259 initially identified patients, 30 were excluded owing to a lack of imaging or clinical data and 43 because iatrogenic renal infarction. In the 186 studied patients, dissection was observed in 76 patients (40.8%) and occlusion in 75 (40.3%). Renal infarction mechanisms were 'renal artery lesion' (n = 151; 81.2%), 'embolic' (n = 17; 9.1%), 'thrombophilic' (n = 11; 5.9%) and 'idiopathic' (n = 7; 3.8%). Predominant renal artery lesions were atherosclerosis disease (n = 52; 34.4%) followed by dissecting hematoma (n = 35; 23.2%) and fibromuscular dysplasia (n = 29; 19.2%). Right and left kidneys were equally involved.
CONCLUSION: Renal artery lesion is the most frequent cause of renal infarction. This result underlines the need for extensive arterial exploration to identify the renal infarction mechanism and, in case of renal artery lesion, the underlying vascular disease.

Entities:  

Mesh:

Year:  2018        PMID: 29045340     DOI: 10.1097/HJH.0000000000001588

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  A rare cause of abdominal pain managed unconventionally: acute renal infarction caused by atrial fibrillation: a case report.

Authors:  Tao Ge; ZhengCai Zhu; Jinfeng Wang; Wenjiao Zhou; Evelyn J Song; Shengxing Tang
Journal:  J Med Case Rep       Date:  2022-10-19

2.  Renal arteriography with endovascular ultrasound for the management of renal infarction patients.

Authors:  Fabrice Ivanes; Jean Dewaele; Caroline Touboul; Philippe Gatault; Bénédicte Sautenet; Christelle Barbet; Matthias Büchler; Laurent Quilliet; Denis Angoulvant; Jean-Michel Halimi
Journal:  BMC Nephrol       Date:  2020-07-14       Impact factor: 2.388

3.  Idiopathic Renal Infarction and Anticoagulation.

Authors:  Maurice I Khayat; Robert Nee; Dustin J Little; Stephen W Olson
Journal:  TH Open       Date:  2019-10-09

4.  A COVID-19 Patient with Simultaneous Renal Infarct, Splenic Infarct and Aortic Thrombosis during the Severe Disease.

Authors:  Georgios Mavraganis; Sofia Ioannou; Anastasios Kallianos; Gianna Rentziou; Georgia Trakada
Journal:  Healthcare (Basel)       Date:  2022-01-13

5.  Use of contrast-enhanced computed tomography to detect kidney infarction in dogs.

Authors:  Somchin Sutthigran; Phasamon Saisawart; Auraiwan Klaengkaew; Kongthit Horoongruang; Nardtiwa Chaivoravitsakul; Kiatpichet Komin; Chutimon Thanaboonnipat; Nan Choisunirachon
Journal:  J Vet Intern Med       Date:  2021-12-24       Impact factor: 3.333

6.  Bilateral Acute Renal Infarction Due to Paradoxical Embolism in a Patient with Eisenmenger Syndrome and a Ventricular Septal Defect.

Authors:  Sehyun Jung; Seunghye Lee; Ha Nee Jang; Hyun Seop Cho; Se-Ho Chang; Hyun-Jung Kim
Journal:  Intern Med       Date:  2021-06-19       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.